The price of the stock right now did NOT include todays decision. NAVB got approved and tanked because the price of the stock had built in approval. Long time investor here, i say it doubles tomorrow. I wouldnt be surprised to see $3.
Prep panel and media trashed it on the 19th even though they did not understand the data. But people are nervous that some of their dosage comments might derail this train.
Let me tell you why I think this is wrong.
1. The 2 dosages used by titan were efficacious and safe.
2. Higher and lower doses in drugs are often later found to have other purposes. Right now Tramadol, a pain killer, is going through approval at a lower dose for premature #$%$:/ Another drug going through approval will help macular edema at a low dose, but at a high dose might make you blind.
You can't test every dose for every ailment up and down the spectrum. It is just too expensive, and it might have unintended consequences.